4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial
Authors:
- 1 March 2021
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 22 (3) , 332-340
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK
This publication has 20 references indexed in Scilit:
- Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomasStrahlentherapie und Onkologie, 2018
- Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphomaHead & Neck, 2017
- Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology GroupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trialThe Lancet Oncology, 2014
- Low-Dose Radiation Therapy (2 Gy × 2) in the Treatment of Orbital LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Recommendations for the Use of Radiotherapy in Nodal LymphomaClinical Oncology, 2012
- Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trialRadiotherapy and Oncology, 2011
- Localized Low-Dose Radiotherapy for Follicular Lymphoma: History, Clinical Results, Mechanisms of Action, and Future OutlooksInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- High Response Rates and Lasting Remissions After Low-Dose Involved Field Radiotherapy in Indolent LymphomasJournal of Clinical Oncology, 2003
- Potential role for low dose limited‐field radiation therapy (2 × 2 grays) in advanced low‐grade non‐Hodgkin's lymphomasHematological Oncology, 1994